Table 1.
Variables | Children (n = 34) | Adults (n = 98) | X2 | P |
---|---|---|---|---|
Sex, n (%) | 0.338 | 0.561 | ||
Male | 14 (41.2) | 46 (46.9) | ||
Female | 20 (46.9) | 52 (53.1) | ||
Age, median (IQR) | 4 y 3 mon (2 mon-10 y) | 18–83 y | ||
Incubation period (d), median (IQR) | 10 (1–30) (n = 31) | 7 (1–29) (n = 72) | -2.001 (Z) | 0.045 |
Duration of pharyngeal swab NAT-positive period (d), median (IQR) | 11 (6–27) (n = 15) | 17 (3 to > 37) (n = 28) | -2.373 (Z) | 0.018 |
Clinical manifestation, n (%) | ||||
Number of asymptomatic infection | 11 (32.4) | 13 (13.3) | 6.182 | 0.013 |
Fever | 15 (44.1) | 61 (62.2) | 3.396 | 0.065 |
Body temperature grading | 0.033 | 0.855 | ||
Low-grade fever | 3 (33.3) (n = 9) | 9 (45.0) (n = 20) | ||
Moderate fever | 6 (66.7) (n = 9) | 11 (55.0) (n = 20) | ||
Cough | 6 (17.6) | 44 (44.9) | 7.966 | 0.005 |
Fatigue | 3 (8.8) | 24 (24.5) | 3.808 | 0.051 |
Myalgia | 0 (0.0) | 11 (11.2) | 2.824 | 0.093 |
Sore throat | 1 (2.9) | 10 (10.2) | 0.922 | 0.337 |
Chest pain | 0 (0.0) | 5 (5.1) | 0.675 | 0.411 |
Polypnea | 0 (0.0) | 3 (3.1) | 0.569 | |
Dyspnea | 0 (0.0) | 2 (2.0) | 1.000 | |
Chest tightness | 0 (0.0) | 4 (4.1) | 0.379 | 0.538 |
Rhiborrhea | 1 (2.9) | 3 (3.1) | 0.000 | 1.000 |
Sneezing | 0 (0.0) | 1 (1.0) | 1.000 | |
Vomiting | 2 (5.9) | 0 (0.0) | 0.065 | |
Diarrhea | 4 (11.8) | 2 (2.0) | 3.488 | 0.062 |
IQR interquartile range, NAT nucleic acid test